Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Menendez Jurors See Staffers’ Emails About Donor’s Dispute

Prosecutors in the bribery trial of U.S. Sen. Bob Menendez and a wealthy friend showed jurors emails Tuesday indicating the New Jersey senator's staffers were getting involved in the friend's multimillion-dollar Medicare billing dispute.

NEWARK, N.J. (AP) — Prosecutors in the bribery trial of U.S. Sen. Bob Menendez and a wealthy friend showed jurors emails Tuesday indicating the New Jersey senator's staffers were getting involved in the friend's multimillion-dollar Medicare billing dispute.

The dispute, which ultimately cost Florida eye doctor Salomon Melgen $8.9 million, is one of the central facets of the indictment against the two men. The government has charged Menendez accepted free flights and luxury hotel stays from Melgen in exchange for lobbying government officials on behalf of Melgen's business interests.

Some of the emails shown to jurors Tuesday dated back to 2009 and included communications between Menendez's staffers and Melgen's lawyers as well as with an attorney for the Center for Medicare and Medicaid Services.

In one email to his chief of staff, Menendez recommended finding out "who has the best juice" at CMS or the Department of Health and Human Services, a phrase prosecutors say was a reference to Menendez's efforts to find out who had the most decision-making power.

The indictment alleges the Democratic senator's subsequent contacts with health officials — including 2012 meetings with then-HHS Secretary Kathleen Sebelius and acting Medicare administrator Marilyn Tavenner — were meant to benefit Melgen, who had given hundreds of thousands of dollars to campaign funds that supported Menendez's re-election that year.

Menendez argued in court filings that he was concerned Medicare reimbursement policies were unfair and enriched drug companies at the expense of doctors. On cross-examination, several witnesses testified Melgen's name wasn't mentioned at the meetings.

The trial is in its sixth week. The prosecution is expected to rest its case next week.

Categories / Criminal, Government, National, Politics, Trials

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...